Mounting evidence implicates medroxyprogesterone acetate in meningioma risk, but mechanisms require further investigation. Braman BC, Raleigh DR. Neuro Oncol 2025 Nov 12:noaf267. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Braman BC, Raleigh DR. Mounting evidence implicates medroxyprogesterone acetate in meningioma risk, but mechanisms require further investigation. Neuro Oncol 2025 Nov 12:noaf267. doi: 10.1093.
PMID: 41230569